Pere Llinàs-Arias

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2- Breast Cancer.

|May 14, 2022
Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype.

Borja Sesé, Sandra Íñiguez-Muñoz, Miquel Ensenyat-Mendez

|Aug 27, 2021
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer.

Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Kelly McCann

|Jan 27, 2021
Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells.

Jeroni Morey, Pere Llinás, Alberto Bueno-Costa

|Sep 22, 2017
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.

Pere Llinàs-Arias, Manel Esteller

Pageof 1

Frequent Collaborators

2 joint publications

Maggie L DiNome

2 joint publications

Diego M Marzese

1 joint publications

Alberto Bueno-Costa

1 joint publications

M Nieves Piña